Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Lifevantage LFVN Stock Recovery Underway Smart Money Active 20260420 Pfizer Inc PFE Affiliated Clinical Biotech Helus Pharma Bolsters Scientific Advisory Board With TopTier Translational and CNS Development Experts Is Ready RCB stock a strong buy Q4 2025 Below Expectations Alset AEI shares gain 055 despite 173 loss per share in Q3 defying bearish expectations Telesat TSAT Stock Key Takeaways In Focus 20260420 The stress test results at 21shares TSUI Marathon Petroleum Corporation MPC Q1 2026 Earnings Preview Mixed Fundamentals Amid Bearish Consensus Revision Headwinds How BioNTech BNTX earnings power stacks up historically Q1 2026 EPS Tops Views AbbVie Inc ABBV Mixed Catalysts and Downside Risks Amid Pipeline Updates and Brokerage Adjustments National EYE Stock Analysis Falls 152 Watching 1658 20260515 SoundHound AI SOUN Q1 2026 Earnings Miss EPS 006 vs 004 Expected Zhibao ZBAO Stock Jumps 264 Approaching 081 20260518 Telos Corporation TLS Falls 189 Watching 394 Support 20260515 Taiwan Semiconductor TSM Navigates Market Dynamics in 2026 Industry Outlook and Strategic Position VLYPO Q1 2026 Earnings Preferred Stock Slips Despite EPS Beat Independent IBCP Q1 2026 Profit Surges Past Wall Street Targets Portillos PTLO Reports Weak Q1 2026 Cost Pressures Weigh on Margins KORE Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Stock Reacts Modestly Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues BLBD Q1 2026 Earnings EPS Beat Drives Stock Higher on Operational Strength ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher CYD Q3 2020 Earnings NearMiss on EPS Stock Gains Despite Slight Disappointment RF Acquisition Corp II RFAI Edges Higher SPAC Stock Nears Key Resistance Levels Aditxt Inc ADTX Plunges 1957 Key Support Level Tested at 019 Sidus Space Inc SIDU Surges Over 21 Key Levels to Watch After Breakout Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten